Quantitative Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-54,273	Closed	-$6.21M	–	644
2020 Q3	$6.21M	Buy	54,273 +33,515	+161%	+$3.62M	0.54%	41
2020 Q2	$2.33M	Buy	+20,758	New	+$2.2M	0.24%	100
2020 Q1	–	Sell	-10,320	Closed	-$1.12M	–	892
2019 Q4	$1.12M	Buy	+10,320	New	+$1.1M	0.03%	427
2019 Q3	–	Sell	-21,262	Closed	-$2.78M	–	820
2019 Q2	$2.78M	Buy	21,262 +13,262	+166%	+$1.71M	0.11%	229
2019 Q1	$1.08M	Buy	+8,000	New	+$995K	0.06%	360
2018 Q4	–	Sell	-9,000	Closed	-$1.25M	–	876
2018 Q3	$1.25M	Buy	+9,000	New	+$1.13M	0.04%	265
2017 Q4	–	Sell	-34,300	Closed	-$4.81M	–	922
2017 Q3	$4.81M	Buy	+34,300	New	+$4.66M	0.05%	338
2017 Q1	–	Sell	-5,900	Closed	-$721K	–	979
2016 Q4	$721K	Sell	5,900 -10,000	-63%	-$1.22M	0.02%	651
2016 Q3	$1.95M	Buy	+15,900	New	+$2.05M	0.06%	317
2015 Q4	–	Sell	-35,500	Closed	-$5.55M	–	897
2015 Q3	$5.55M	Sell	35,500 -33,999	-49%	-$6.2M	0.42%	55
2015 Q2	$12.6M	Buy	+69,499	New	+$12M	1.89%	9
2015 Q1	–	Sell	-4,400	Closed	-$814K	–	773
2014 Q4	$814K	Sell	4,400 -1,200	-21%	-$222K	0.13%	171
2014 Q3	$928K	Buy	+5,600	New	+$920K	0.18%	103
2014 Q2	–	Sell	-11,500	Closed	-$1.75M	–	693
2014 Q1	$1.75M	Buy	11,500 +3,000	+35%	+$477K	0.08%	164
2013 Q4	$1.13M	Buy	+8,500	New	+$1.02M	0.11%	181